Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial [NA]

View source ↗

Summary

This clinical trial compares an artificial intelligence–driven lifestyle intervention to standard lifestyle recommendations for non-alcoholic fatty liver diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Non Alcoholic Fatty Liver Disease | NA | Status: NOT_YET_RECRUITING